Antimicrobial Resistance (AMR) is life-threatening, costly and present in every country in the world. Paratek is fighting the AMR pandemic.
Drug-resistant infections cost the US an annual $20 billion in excess healthcare costs and $35 billion in lost productivity. According to recent research, it's estimated that up to 160,000 in US die from antibiotic resistance per year and almost three-quarters of a million people around the globe annually; by 2050 that could grow to 10 million every year if the trend isn’t slowed.
Paratek’s pipeline of therapeutics addresses the growing scarcity of novel and effective broad-spectrum antibiotics for the treatment of bacterial infections.
Investments, strategic partnerships, defense contracts, and top-tier talent are driving factors in Paratek’s success. They needed a more effective digital marketing strategy, web communications platform, and investor relations platform to increase brand awareness among investors, clinicians, researchers, and potential employees.
Our work began with a digital maturity assessment to define the brand, digital, content, and organizational needs of Paratek Pharmaceuticals. We conducted a series of design sprints to rapidly excavate existing content and brand assets while involving the entire leadership and scientific teams in hands-on concept development and future-state visioning exercises
Agency 39A developed a digital strategy that defined content, brand identity, user experience, and digital marketing tactics and a content strategy that informed new mission, vision, values, and value proposition content. A content-managed corporate website improved brand awareness and talent acquisition.
In addition to the development of the corporate website, our design team also created and developed a separate Medical Affairs website for healthcare professionals seeking additional prescribing, efficacy, and data, creating a communications platform for clinicians and Paratek to exchange critical information.
Real-time stock performance, financial performance, and SEC filings are managed in a robust, real-time data environment on a custom-developed integrated Investor Relations (IR) platform that provides an alternative to the Nasdaq-provided IR solution at a fraction of the cost and with greater flexibility and functionality.
Leveraging user insights, research, business strategy UX design, we’ve evolved the digital brand to help Paratek Pharmaceuticals achieve its communication and awareness goals and continue to serve Paratek as a strategic design and technology partner in an ongoing partnership.
Our ADA-compliant digital platforms included a reimagined content strategy, more effective keyword rich content, and robust scientific content for healthcare professionals, ensuring that the website and other digital communications tools were designed to highlight the broad applicability of Paratek’s pipeline of therapeutics, the culture of innovation that drives the team, and the opportunities for researchers wishing to join a cutting-edge team.
Our content-managed Medical Affairs website provides access to Medical Information Requests, Publications, Presentations, Grants, Funding, Product Resources, and Disease Education Resources and a robust IR platform reports corporate governance, stock price, SEC filings, news, presentations, information requests, and FAQs.
Book a call with Agency 39A and learn how we can help you establish your brand, create engagement, and build digital capabilities that drive results for your businesses.